Although we did not find evidence for a MuRF-1/MAFbx- dependent treatment effect of HM01, previous studies demonstrated a blockade of MuRF-1/MAFbx signaling in tumor-bearing mice following ghrelin treatment [26]. The gene discussed is GHRL; the disease is neoplasm.